Doctor profile · Federal record

Dr. Farrukh Zaidi, MD

Rheumatology Physician (CMS: Rheumatology) · Port Richey, FL

  • NPI 1346292414
  • Accepts Medicare
  • MIPS 75.0 / 100 · 2023
  • 38 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

Operates at 2 locations .

NPPES Updated May 11, 2026
Primary practice
8029 Washington St
Port Richey, FL 346686648
(352) 596-4080
fax (352) 596-2904
Additional location
5382 Spring Hill Dr
Spring Hill, FL 346064562
Mailing address
5400 Pinehurst Dr
Spring Hill, FL 346063833

Credentials & registration

NPPES · NUCC
NPI registered
May 2006 — 20 yrs on file
Profile last updated
February 18, 2026
Year of graduation
1988 — 38 yrs since
Specialty taxonomy
207RR0500X — NUCC code
State license (1)
Florida #ME0063405
Medicaid
FL #008471000

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1346292414. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
27,039
Distinct HCPCS
10
Medicare allowed
$933,331
HCPCS Description Services Patients Avg allowed
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 11,225 22 $42
J1602 Injection, golimumab, 1 mg, for intravenous use 7,300 11 $13
J0897 Injection, denosumab, 1 mg 4,440 51 $23
J1745 Injection, infliximab, excludes biosimilar, 10 mg 2,173 13 $33
99214 Established patient office or other outpatient visit, 30-39 minutes 712 316 $125
96413 Administration of chemotherapy into vein, 1 hour or less 268 46 $124
96415 Administration of chemotherapy into vein, each additional hour 122 13 $27
J1040 Injection, methylprednisolone acetate, 80 mg 121 97 $12
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle 117 40 $69
99213 Established patient office or other outpatient visit, 20-29 minutes 103 82 $88

In context: peer comparison

Among 2 peers in Port Richey Rheumatology Physician, average services per provider: 966. This provider delivers 28× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$130
Transactions
6
Manufacturers
6
Payer (manufacturer) Industry Txns Amount
Organon LLC 1 $25.61
Pfizer INC. 1 $25.61
GlaxoSmithKline, LLC. 1 $24.82
Sobi, INC 1 $19.25
Amgen INC. 1 $17.83
Genzyme Corporation 1 $16.60

By nature of payment

Food and Beverage
$110
Education
$19

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
3,591
Patients
973
Total drug cost
$3,842,233
Drug Type Claims Patients Total cost
Prednisone Generic 1,035 304 $10,315
Methotrexate (Methotrexate Sodium) Brand 703 180 $20,933
Hydroxychloroquine Sulfate Generic 439 131 $23,867
Humira(Cf) Pen (Adalimumab) Brand 216 23 $1,889,491
Gabapentin Generic 173 54 $2,900
Meloxicam Generic 161 66 $696
Folic Acid Generic 143 47 $555
Tramadol Hcl Generic 125 29 $503
Enbrel Mini (Etanercept) Brand 103 17 $763,731
Celecoxib Generic 94 31 $3,638

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Farrukh Zaidi's medical specialty?
Dr. Farrukh Zaidi practices Rheumatology Physician in Port Richey, FL.
Where does Dr. Farrukh Zaidi practice?
Dr. Farrukh Zaidi practices at 8029 Washington St, Port Richey, FL 346686648. Office phone: 3525964080.
What is Dr. Farrukh Zaidi's NPI?
Dr. Farrukh Zaidi's National Provider Identifier (NPI) is 1346292414, issued by NPPES.
Does Dr. Farrukh Zaidi accept Medicare assignment?
Yes. Dr. Farrukh Zaidi accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Farrukh Zaidi commonly perform?
Top Medicare-reported procedures in 2023: Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0129); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602); Injection, denosumab, 1 mg (HCPCS J0897). Source: CMS Medicare Physician & Other Practitioners file.